[ad_1]
Aspira Ladies’s Well being (NASDAQ:AWH – Get Ranking) was upgraded by Zacks Funding Analysis from a “maintain” ranking to a “purchase” ranking in a analysis be aware issued on Friday, Zacks.com reviews. The brokerage presently has a $0.75 value goal on the inventory. Zacks Funding Analysis‘s value goal would counsel a possible upside of 26.33% from the inventory’s earlier shut.
In accordance with Zacks, “Aspira Ladies’s Well being Inc. engaged within the discovery, improvement and commercialization of testing choices and bio-analytical options for ladies’s well being. Aspira Ladies’s Well being Inc., previously often called Vermillion Inc., relies in AUSTIN, Texas. “
Shares of NASDAQ AWH traded down $0.02 throughout buying and selling on Friday, hitting $0.59. The corporate had a buying and selling quantity of 402,463 shares, in comparison with its common quantity of 716,369. The inventory has a fifty day easy shifting common of $0.71 and a two-hundred day easy shifting common of $1.15. Aspira Ladies’s Well being has a fifty-two week low of $0.32 and a fifty-two week excessive of $6.02. The agency has a market capitalization of $66.62 million, a price-to-earnings ratio of -1.92 and a beta of two.89. The corporate has a fast ratio of 4.82, a present ratio of 4.85 and a debt-to-equity ratio of 0.12.
Aspira Ladies’s Well being (NASDAQ:AWH – Get Ranking) final introduced its earnings outcomes on Wednesday, Might eleventh. The corporate reported ($0.08) earnings per share (EPS) for the quarter, assembly the consensus estimate of ($0.08). Aspira Ladies’s Well being had a adverse internet margin of 485.64% and a adverse return on fairness of 102.03%. Throughout the identical interval final yr, the enterprise earned ($0.05) EPS. On common, analysts anticipate that Aspira Ladies’s Well being will put up -0.3 earnings per share for the present yr.
In different Aspira Ladies’s Well being information, insider Valerie Barber Palmieri bought 43,994 shares of the inventory in a transaction that occurred on Monday, Might sixteenth. The shares had been bought at a mean price of $0.57 per share, for a complete transaction of $25,076.58. Following the completion of the transaction, the insider now owns 267,088 shares of the corporate’s inventory, valued at roughly $152,240.16. The acquisition was disclosed in a submitting with the Securities & Trade Fee, which is accessible at the SEC web site. Additionally, CEO Nicole Sandford purchased 98,000 shares of Aspira Ladies’s Well being inventory in a transaction on Monday, Might sixteenth. The shares had been bought at a mean price of $0.76 per share, for a complete transaction of $74,480.00. Following the completion of the acquisition, the chief government officer now immediately owns 136,160 shares of the corporate’s inventory, valued at $103,481.60. The disclosure for this buy might be discovered right here. Insiders personal 4.50% of the corporate’s inventory.
A lot of hedge funds have just lately modified their holdings of AWH. Citigroup Inc. raised its stake in shares of Aspira Ladies’s Well being by 58.6% within the third quarter. Citigroup Inc. now owns 9,211 shares of the corporate’s inventory valued at $30,000 after buying a further 3,405 shares through the interval. Royal Financial institution of Canada raised its stake in shares of Aspira Ladies’s Well being by 57.3% within the 2nd quarter. Royal Financial institution of Canada now owns 9,347 shares of the corporate’s inventory valued at $53,000 after buying a further 3,403 shares through the interval. Balyasny Asset Administration LLC bought a brand new stake in shares of Aspira Ladies’s Well being within the third quarter valued at roughly $34,000. Macquarie Group Ltd. bought a brand new stake in shares of Aspira Ladies’s Well being within the third quarter valued at roughly $49,000. Lastly, Non-public Advisor Group LLC bought a brand new stake in shares of Aspira Ladies’s Well being within the 4th quarter valued at roughly $27,000. 54.01% of the inventory is presently owned by institutional buyers.
About Aspira Ladies’s Well being (Get Ranking)
Aspira Ladies’s Well being Inc, along with its subsidiaries, engages in growing and commercializing diagnostic checks for gynecologic illness in the USA. The corporate gives OVA1, OVERA, and OVA1plus to detect threat of ovarian malignancy in ladies with adnexal plenty. It additionally gives ASPiRA GenetiX, a genetic take a look at for the danger of gynecologic most cancers.
See Additionally
Get a free copy of the Zacks analysis report on Aspira Ladies’s Well being (AWH)
For extra details about analysis choices from Zacks Funding Analysis, go to Zacks.com
Obtain Information & Rankings for Aspira Ladies’s Well being Day by day – Enter your e mail tackle beneath to obtain a concise day by day abstract of the newest information and analysts’ scores for Aspira Ladies’s Well being and associated corporations with MarketBeat.com’s FREE day by day e mail e-newsletter.
[ad_2]
Supply hyperlink